Machine Learning-Driven Drug Repurposing for KRAS G12C and KRAS G12D Inhibition
Gianluca Fuschi, J Germain, David Bebensee, Christophe Moawad, Arina Aladysheva, Ashraf Mohamed, Bernard R. Brooks, Rajkumar Savai, Eiman Elwakeel, Muhamed Amin
This study uses machine learning to screen FDA-approved compounds for KRAS G12C and G12D inhibition, identifying potential drug candidates for further experimental validation.
ACS Omega · May 22, 2026Peer-reviewedCancer Biology